Scinai Immunotherapeutics LT
13F holders, Q4 2025 (December 31)7holders +1
2new positions
1sold out
1famous investor
$0.71avg. 13F price*
At the end of Q4 2025, 7 institutions reported holding Scinai Immunotherapeutics LT in their 13F filings, up 1 from Q3 2025. 2 opened new positions and 1 sold out. The largest holders were Citadel Advisors ($25K), XTX Topco Ltd ($19K) and Virtu Financial LLC ($11K). One famous investor held it Ken Griffin (0.0% of Citadel Advisors's portfolio).
- Company
- Scinai Immunotherapeutics LT
- CUSIP
- 09073Q303
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q3 2025 → Q4 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 2 | $30K |
| Exits | 1 | $19K |
All 13F filers, Q3 2025 → Q4 2025: 50,375 shares bought and 16,558 shares sold, net +33,817 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 7 holders
| Citadel Advisors | 0.00% | Add +20.7% | 34,562 | $25K |
| XTX Topco Ltd | 0.00% | New | 27,294 | $19K |
| Virtu Financial LLC | 0.00% | New | 15,409 | $11K |
| Rhumbline Advisers | 0.00% | Reduce -47.1% | 1,878 | $1K |
| UBS Group AG | 0.00% | Add +21750.0% | 1,748 | $1K |
| Northwestern Mutual Wealth Management Co. | 0.00% | No change | 1,000 | $712 |
| Morgan Stanley | 0.00% | Reduce -76.3% | 58 | $41 |
"% of holder's portfolio" is SCINAI IMMUNOTHERAPEUTICS LT's weight in each manager's 13F, not the share of Scinai Immunotherapeutics LT the manager owns.